EP Patent

EP1686972B1 — Sprayable composition for the administration of vitamin d derivatives

Assigned to Galderma Research and Development SNC · Expires 2008-03-12 · 18y expired

What this patent protects

The invention relates to a composition in the form of a spray comprising calcitriol, at least one volatile silicone and a nonvolatile oily phase in a physiologically acceptable medium, to the process for preparing it and to its use in cosmetics and in dermatology.

USPTO Abstract

The invention relates to a composition in the form of a spray comprising calcitriol, at least one volatile silicone and a nonvolatile oily phase in a physiologically acceptable medium, to the process for preparing it and to its use in cosmetics and in dermatology.

Drugs covered by this patent

Patent Metadata

Patent number
EP1686972B1
Jurisdiction
EP
Classification
—
Expires
2008-03-12
Drug substance claim
No
Drug product claim
No
Assignee
Galderma Research and Development SNC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.